Evidence map›Paper›PMID 24345818›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase.

Elise E DeVito, Aryeh I Herman, Andrew J Waters, Gerald W Valentine, Mehmet Sofuoglu

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Pooled it
  2. Trial
  3. Trial
  4. The effects of inhaled flavors on intravenous nicotine.Experimental and clinical psychopharmacology · 2021
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Intravenous Nicotine Self-Administration in Smokers: Dose-Response Function and Sex Differences.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Trial
  10. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elise E DeVitoDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Aryeh I Herman1] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA [2] VA Connecticut Healthcare System, West Haven, CT, USA.
Andrew J WatersDepartment of Medical and Clinical Psychology, Uniformed Services University of the Health Science, Bethesda, MD, USA.
Gerald W Valentine1] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA [2] VA Connecticut Healthcare System, West Haven, CT, USA.
Mehmet Sofuoglu1] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA [2] VA Connecticut Healthcare System, West Haven, CT, USA.

Funding

SUBSTANCE ABUSEK12DA000167 · NIDA · YALE UNIVERSITY · PI STEPHANIE S O'MALLEY, Marc N Potenza · 1991 to 2026
$17.7M
Sex-specific analysis of opioid dependence GWAS and beyondR01DA012690 · NIDA · YALE UNIVERSITY · PI GELERNTER, JOEL · 2000 to 2017
$14.0M
GENETICS OF COCAINE DEPENDENCER01DA012849 · NIDA · YALE UNIVERSITY · PI GELERNTER, JOEL · 1999 to 2010
$11.5M
Yale BIRCWH Scholar Program on Women's Health and Addictive BehaviorsK12DA031050 · NIDA · YALE UNIVERSITY · PI MAZURE, CAROLYN M. · 2010 to 2014
$2.5M
Sensitivity to intravenous nicotine: genetic moderatorsR03DA027474 · NIDA · YALE UNIVERSITY · PI HERMAN, ARYEH ISAAC, SOFUOGLU, MEHMET · 2009 to 2010
$384k
NIDA NIH HHS K12 DA000167NIDA NIH HHS K12 DA00167NIDA NIH HHS K12 DA031050NIDA NIH HHS R01 DA012690NIDA NIH HHS R01 DA012849NIDA NIH HHS R01 DA12690NIDA NIH HHS R01 DA12849NIDA NIH HHS R03 DA027474
6 · The paper itself

Abstract

Nicotine dependence is a serious public health concern. Optimal treatment of nicotine dependence will require greater understanding of the mechanisms that contribute to the maintenance of smoking behaviors. A growing literature indicates sex and menstrual phase differences in responses to nicotine. The aim of this study was to assess sex and menstrual phase influences on a broad range of measures of nicotine response including subjective drug effects, cognition, physiological responses, and symptoms of withdrawal, craving, and affect. Using a well-established intravenous nicotine paradigm and biochemical confirmation of overnight abstinence and menstrual cycle phase, analyses were performed to compare sex (age 18-50 years; 115 male and 45 female) and menstrual cycle phase (29 follicular and 16 luteal) effects. Females had diminished subjective drug effects of, but greater physiological responses to, nicotine administration. Luteal-phase females showed diminished subjective drug effects and better cognition relative to follicular-phase women. These findings offer candidate mechanisms through which the luteal phase, wherein progesterone is dominant relative to estradiol, may be protective against vulnerability to smoking.

Indexed as

Administration, IntravenousAdolescentAdultAffectCognitionDose-Response Relationship, DrugDrug-Seeking BehaviorFemaleFollicular PhaseHumansLuteal PhaseMaleMiddle AgedNicotineNicotinic AgonistsSex FactorsNicotineNicotinic Agonists

Identifiers

PMID24345818
PMCPMC3988546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.